Profile
MESO VRTX REGN SGEN ALNY ARGX
Company Name Mesoblast Limited Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $1.38B $116.96B $55.30B $43.15B $41.50B $33.28B
Employees 0.07K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Silviu Itescu FACP, FACRA, FRACP, MBBS Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
MESO VRTX REGN SGEN ALNY ARGX
Quant Rating Score 1 2 4 3 1 2
Quant Rating Strong Sell Sell Buy Neutral Strong Sell Sell
Trading
MESO VRTX REGN SGEN ALNY ARGX
Last Close $10.86 $457.03 $547.74 $228.74 $329.77 $545.11
High 52 $21.04 $516.74 $1201.76 $228.74 $329.77 $671.75
Low 52 $5.84 $396.64 $482.92 $228.74 $224.58 $435.29
Price vs. 52 Week High -48.38 % -11.56 % -54.42 % 0 % 0 % -18.85 %
Price vs. 52 Week Low 85.96 % 15.23 % 13.42 % 0 % 46.84 % 25.23 %
Total Return
MESO VRTX REGN SGEN ALNY ARGX
1 Month Return 2.74 % 2.36 % 12.32 % 0 % 8.53 % -5.46 %
3 Month Return -6.38 % -5.57 % -10.24 % 0 % 25.81 % -7.43 %
6 Month Return -46.02 % 12.26 % -23.73 % 0 % 40.76 % -12.18 %
9 Month Return 13.72 % 0.77 % -46.01 % 0 % 22.35 % 0.39 %
YTD Return -45.15 % 13.49 % -23.11 % 0 % 40.14 % -11.36 %
1 Year Return 59.59 % -2.82 % -46.51 % 0 % 32.61 % 25.23 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MESO VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.34 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -88.65 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
MESO VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM -398 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -15.82 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -21.95 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -14.68 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100.12 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 121.08 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM -1503.59 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -16.38 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM 3.36 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 2.38 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM 1.17 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM 91.17 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM 0.87 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -0.02 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -0.02 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 3.33 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -364.29 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.03 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -16.38 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -64.33 -92.97 18.31 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM -58.7 -119.36 14.06 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM -58.7 -119.36 14.06 -93.1 -914.84 -515.98
Income Statement (TTM)
MESO VRTX REGN SGEN ALNY ARGX
Revenue $0.01B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $-0.04B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio -595.87% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.06B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.09B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -0.89 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
MESO VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.1B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.19B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.48B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0.12B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.67B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
MESO VRTX REGN SGEN ALNY ARGX
Net Income $-0.09B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.05B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.76
AARD Aardvark Therapeutics, Inc. Common Stock 13.2
ABCL AbCellera Biologics Inc. 3.695
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.86
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.14
ABPWW 0.0222
ABSI Absci Corporation 2.765
ABUS Arbutus Biopharma Corporation 3.245
ABVC ABVC BioPharma, Inc. 3.0447
ABVX Abivax SA American Depositary Shares 7.87
ACAD ACADIA Pharmaceuticals Inc. 21.185
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6008
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.2492
ACIU AC Immune SA 2.015
ETFs With Exposure to MESO
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.10366 129.68
BIB ProShares Ultra Nasdaq Biotechnology 0.0395604 48.16
IBBQ Invesco Nasdaq Biotechnology ETF 0.055 21.675
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.05518 5.357
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.05518 6.3025
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.05518 6.279
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.05518 4.624
Unlock